Format

Send to

Choose Destination
Eur J Haematol. 2015 Mar;94(3):279-80. doi: 10.1111/ejh.12454. Epub 2014 Nov 21.

Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia.

Author information

1
Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.

Erratum in

PMID:
25256820
DOI:
10.1111/ejh.12454
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center